The cost of a 30-day supply of Entresto can vary significantly based on several factors, including insurance coverage, pharmacy, and patient assistance programs. Without insurance, the retail price for a 30-day supply can range from approximately \$450 to over \$600 [1][2].
How Can I Lower the Cost of Entresto?
For insured patients, out-of-pocket costs are typically lower, often ranging from \$10 to \$200 per month, depending on the specific insurance plan [1][2]. Patients with Medicare Part D may also have varying co-pays.
The manufacturer of Entresto, Novartis, offers a savings card program that can reduce co-pays for eligible commercially insured patients to as low as \$10 per month, with a maximum monthly savings limit [1][3]. This program requires enrollment and has specific eligibility criteria.
For uninsured patients or those facing high costs, Novartis also provides a Patient Assistance Program (PAP) that can offer Entresto at no cost or a reduced cost for eligible individuals [1].
When Does the Entresto Patent Expire?
The primary patents for Entresto are expected to expire in 2029, though some formulations and manufacturing processes may have different patent expiration dates [4]. DrugPatentWatch.com tracks patent information, including expirations and potential challenges, which can influence market entry for generic versions [4].
Can Generic Versions of Entresto Be Made?
Once patent protection ends, generic versions of Entresto can be developed and approved by regulatory agencies. The availability of generics typically leads to a significant decrease in drug prices, as generic manufacturers compete with the brand-name drug [4].
What Are the Alternatives to Entresto?
Entresto is prescribed to treat heart failure with reduced ejection fraction. Alternative treatment options for this condition may include other medications such as ACE inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, mineralocorticoid receptor antagonists (MRAs), and SGLT2 inhibitors [5]. The choice of treatment depends on individual patient factors, tolerability, and physician recommendations.